Replies to post #1178 on Axim Biotechnologies Inc (AXIM)

[StockRoomBully]

Good breakdown. We dont spend out time back and forth. Hedge fund$ loading.. Do y'all really think for the past few days all those $$millions volume is all ihub bought? we have no time to waste on those who dont get it or just plane have an agenda.

We have supported the facts why Axim NeuCovixTM is highly important. Oneblood went up 500% see qoute

From May until now in comparison, we've had an increase of over 500 percent in the demand from hospitals," said Susan Forbes with OneBlood. "Now we're being told that we're using this more often with people who are not in the ICU but having breathing problems."

We also supported facts how this is becoming a norm having this tool. The University of Rockefeller

Researchers at The Rockefeller University in New York have developed new tools to rapidly test the ability of antibodies to neutralize SARS-CoV-2, the novel coronavirus responsible for the COVID-19 pandemic. The approach, described today in the Journal of Experimental Medicine (JEM), will help researchers understand whether patients are susceptible to reinfection by SARS-CoV-2 and assess the effectiveness of experimental vaccines, as well as develop antibody-based therapies against the disease.

From Rockerfeller University own wording.. "re-infection experimental vaccines"

"Will help researchers understand whether patients are susceptible to reinfection by SARS-CoV-2 and assess the effectiveness of experimental vaccines"

What folks don't understand?
Press release from $Axim own wording

"Another application of NeuCovixTM is to help ensure that vaccines elicit high levels of neutralizing antibodies. When a vaccine is available, manufacturers can employ the NeuCovixTM rapid, point-of-care test to evaluate protective immune responses in vaccine recipients.

DID YOU GET IT? VACCINE AVAILABLE MANUFACTURERS CAN EMPLOY THE NeuCovixTM

AXIM® Biotech CEO John W. Huemoeller II commented, “Our goal was to make this test, accurate, fast and relatively inexpensive so it could serve as an ‘Immunity Passport port™’ for vaccine developers around the world as they begin larger Phase II and III clinical trials. We are optimistic that NeuCovixTM will be widely used, becoming the gold standard in assessing levels of immunity.”


What did $Axim filed. "The intellectual property relating to the novel serological test is the subject of Provisional Patent Application No. 63/023,646 “Convalescent Plasma Testing and Treatment” filed on May 12, 2020.

Google search results:convalescent plasma test tool



Scientists develop safe, rapid Covid-19 antibody test

"The first Phase 3 coronavirus vaccine trial in the US is expected to begin next week. Here's how the vaccine works"
By Andrea Kane, CNN
Updated 9:22 PM EDT, Fri July 24, 2020

The other reason you do Phase 1 trials is to not just find the dose that's tolerable but find the dose that has optimal immunogenicity. In this case, the 100µg dose was virtually the same as the 250µg dose in terms of the antibodies made. And those antibodies reached levels that were in that upper range of what convalescent people make who have been infected with the SARS-CoV-2 coronavirus. So, we felt like this was a good outcome.

Covid not going away tomorrow is it? Smh
This test is needed is it?




https://www.wtxl.com/news/local-news/oneblood-collecting-plasma-from-recovered-covid-19-patients


https://medicalxpress.com/news/2020-07-tools-rapidly-anti-coronavirus-antibodies.html

https://www.cnn.com/2020/07/24/health/moderna-vaccine-barney-graham-gupta/index.html

[Buddy124]

100% agree. I don't care that others don't get it. As long as I get in.